Tara Clanton, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 604 Christopher St, Quitman, TX 75783 Phone: 903-738-8505 |
Dyess Gardner, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2192 State Highway 182, Quitman, TX 75783 Phone: 903-638-4099 |
Andrew Tarbutton, FNP-C Registered Nurse Medicare: Medicare Enrolled Practice Location: 627 E Lane St, Quitman, TX 75783 Phone: 903-283-1861 |
Kelly Whiddon, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 330 County Road 2150, Quitman, TX 75783 Phone: 903-497-2855 |
News Archive
A London, Canada scientist studying cystic fibrosis (CF) has successfully corrected the defect which causes the overproduction of intestinal mucous in mice.
Inhibitex, Inc. today announced that the independent data safety monitoring board (DSMB) responsible for reviewing safety data from the Company's ongoing Phase II clinical trial of FV-100 met, as scheduled, after the Company had provided it with complete 30-day follow-up safety data on the third quartile (75%) of the patients that the Company plans to enroll in the trial. Based upon its review, the DSMB recommended that the trial continue to completion without modification.
In the quest to detect more types of cancers at ever earlier stages, researchers have been stymied by a lack of cell surface markers that distinguish in a clear-cut manner between healthy and malignant cells.
A team of bioengineers from Rice University is bringing a promising new strategy for growing replacement heart valves closer to reality, thanks to a four-year, $1.2 million grant from the National Institutes of Health. The team hopes to use gel-like materials to generate three-dimensional patterns called scaffolds that can simultaneously mimic the complex structural and physical properties of heart-valve tissues and guide the behavior of tissue-forming cells.
› Verified 7 days ago